$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

$lfcr Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000100528622000020 Filed on April 07, 2022

Income Statement

Concept	2022 Q2	2022 Q1	2021 Q4
Revenue	$47.63M	$53.07M	$129.5M
YoY Change	-65.94%	18.76%	-1.08%
Cost Of Revenue	$36.30M	$39.18M	$116.5M
YoY Change	-68.44%	29.52%	5.65%
Gross Profit	$12.11M	$13.90M	$12.99M
YoY Change	-51.16%	-3.78%	-37.05%
Gross Profit Margin	25.43%	26.18%	10.03%
Selling, General & Admin	$18.92M	$9.725M	$13.84M
YoY Change	17.25%	19.56%	-14.1%
% of Gross Profit	156.21%	69.99%	106.49%
Research & Development	$2.056M	$2.056M	$2.718M
YoY Change	-20.28%	11.56%	5.68%
% of Gross Profit	16.97%	14.8%	20.92%
Depreciation & Amortization	$3.396M	$3.529M	$5.905M
YoY Change	-32.85%	-29.14%	24.84%
% of Gross Profit	28.04%	25.4%	45.45%
Operating Expenses	$20.98M	$17.65M	$50.02M
YoY Change	12.08%	47.05%	126.31%
Operating Profit	-$8.864M	-$3.751M	-$37.03M
YoY Change	-245.67%	-253.67%	2425.92%
Interest Expense	-$3.465M	$4.105M	$4.333M
YoY Change	-26.59%	39.67%	42.58%
% of Operating Profit
Other Income/Expense, Net	$5.813M	$454.0K	$79.00K
YoY Change	12268.09%	530.56%	-100.67%
Pretax Income	-$36.59M	-$7.382M	-$41.27M
YoY Change	963.44%	384.7%	157.89%
Income Tax	-$827.0K	-$276.0K	-$2.824M
% Of Pretax Income
Net Earnings	-$36.66M	-$12.85M	-$38.44M
YoY Change	1179.24%	133.72%	189.01%
Net Earnings / Revenue	-76.98%	-24.21%	-29.69%
Basic Earnings Per Share	-$1.88	-$0.24	-$1.30
Diluted Earnings Per Share	-$1.243M	-$0.43	-$1.30
COMMON SHARES
Basic Shares Outstanding	29.48M shares	29.48M shares	29.47M shares
Diluted Shares Outstanding		29.48M shares	29.47M shares

Balance Sheet

Concept	2022 Q2	2022 Q1	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.643M	$1.854M	$1.091M
YoY Change	26.87%	-15.73%	-56.36%
Cash & Equivalents	$1.643M	$1.854M	$1.091M
Short-Term Investments
Other Short-Term Assets	$7.052M	$6.924M	$8.721M
YoY Change	-4.05%	-51.58%	-37.26%
Inventory	$66.85M	$73.70M	$79.43M
Prepaid Expenses
Receivables	$48.17M	$49.56M	$65.28M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$123.7M	$132.0M	$154.5M
YoY Change	-16.59%	-18.96%	0.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$130.4M	$123.2M	$179.9M
YoY Change	15.63%	-26.96%	5.24%
Goodwill	$13.88M	$33.92M	$37.33M
YoY Change	-59.07%	-51.12%	-46.2%
Intangibles	$8.400M	$17.10M	$25.33M
YoY Change	-50.88%	307.14%	503.05%
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$3.002M	$3.048M	$3.239M
YoY Change	-14.98%	-14.69%	143.17%
Total Long-Term Assets	$171.4M	$193.5M	$267.6M
YoY Change	-51.65%	-44.21%	-22.43%
TOTAL ASSETS
Total Short-Term Assets	$123.7M	$132.0M	$154.5M
Total Long-Term Assets	$171.4M	$193.5M	$267.6M
Total Assets	$295.2M	$325.6M	$422.1M
YoY Change	-41.31%	-36.14%	-15.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.80M	$20.01M	$59.10M
YoY Change	-3.04%	-64.47%	-2.95%
Accrued Expenses	$18.63M	$28.54M	$20.01M
YoY Change	-22.6%	8.09%	-17.33%
Deferred Revenue	$919.0K	$1.614M	$1.160M
YoY Change	44.27%	1.19%	80.12%
Short-Term Debt	$40.00M	$39.90M	$42.00M
YoY Change	37.93%	-2.68%	-45.45%
Long-Term Debt Due	$599.0K	$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$79.23M	$90.07M	$122.3M
YoY Change	-22.24%	-28.15%	-29.7%
LONG-TERM LIABILITIES
Long-Term Debt	$97.58M	$79.60M	$124.2M
YoY Change	-40.83%	-45.12%	51.46%
Other Long-Term Liabilities	$190.0K	$544.0K	$3.894M
YoY Change	-93.38%	-85.54%	-27.31%
Total Long-Term Liabilities	$97.77M	$80.14M	$128.1M
YoY Change	-41.73%	-46.15%	46.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$79.23M	$90.07M	$122.3M
Total Long-Term Liabilities	$97.77M	$80.14M	$128.1M
Total Liabilities	$187.2M	$181.5M	$265.9M
YoY Change	-37.62%	-40.53%	-8.37%
SHAREHOLDERS EQUITY
Retained Earnings	-$58.85M	-$22.19M	-$9.338M
YoY Change	-252.54%	-153.53%	-119.89%
Common Stock	$30.00K	$29.00K	$29.00K
YoY Change	3.45%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$107.9M	$144.1M	$156.2M
YoY Change
Total Liabilities & Shareholders Equity	$295.2M	$325.6M	$422.1M
YoY Change	-41.31%	-36.14%	-15.43%

Cashflow Statement

Concept	2022 Q2	2022 Q1	2021 Q4
OPERATING ACTIVITIES
Net Income	-$36.66M	-$12.85M	-$38.44M
YoY Change	1179.24%	133.72%	189.01%
Depreciation, Depletion And Amortization	$3.396M	$3.529M	$5.905M
YoY Change	-32.85%	-29.14%	24.84%
Cash From Operating Activities	$36.00K	-$20.13M	-$5.137M
YoY Change	-99.18%	156.09%	-456.74%
INVESTING ACTIVITIES
Capital Expenditures	-$9.595M	-$5.529M	-$5.097M
YoY Change	-22.55%	39.27%	82.69%
Acquisitions
YoY Change
Other Investing Activities	-$9.794M	$73.51M	$0.00
YoY Change	-42682.61%		-100.0%
Cash From Investing Activities	-$19.39M	$67.99M	-$5.097M
YoY Change	56.92%	-1808.17%	-197.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	19.14M	-47.09M	9.878M
YoY Change	173.81%	-506.32%	-298.35%
NET CHANGE
Cash From Operating Activities	36.00K	-20.13M	-5.137M
Cash From Investing Activities	-19.39M	67.99M	-5.097M
Cash From Financing Activities	19.14M	-47.09M	9.878M
Net Change In Cash	-211.0K	763.0K	-356.0K
YoY Change	-77.74%	-405.2%	-120.82%
FREE CASH FLOW
Cash From Operating Activities	$36.00K	-$20.13M	-$5.137M
Capital Expenditures	-$9.595M	-$5.529M	-$5.097M
Free Cash Flow	$9.631M	-$14.60M	-$40.00K
YoY Change	-42.69%	275.32%	-100.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001005286
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-29
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q1	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2022Q1	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
CY2021Q1	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2021-01-31#ProductMember
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-02-27
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-27446
	dei	Entity Registrant Name EntityRegistrantName	LANDEC CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	94-3025618
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2811 Airpark Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Maria,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93455
	dei	City Area Code CityAreaCode	650
	dei	Local Phone Number LocalPhoneNumber	306-1650
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	LNDC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29482538	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1854000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1159000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	49559000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41430000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	73700000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	63076000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6924000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5038000	USD
CY2022Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2021Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	37618000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	132037000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	148321000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	123209000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	112770000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8796000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7480000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	33916000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	33916000	USD
CY2022Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	17100000	USD
CY2021Q2	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	17100000	USD
CY2022Q1	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	7476000	USD
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	14759000	USD
CY2021Q2	lndc	Finite Lived Customer Lists Net FiniteLivedCustomerListsNet	8532000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3048000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3531000	USD
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	0	USD
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	171274000	USD
CY2022Q1	us-gaap	Assets Assets	325582000	USD
CY2021Q2	us-gaap	Assets Assets	502924000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	20014000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	16298000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9757000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7754000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13735000	USD
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3955000	USD
CY2022Q1	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	5045000	USD
CY2021Q2	lndc	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	1465000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1614000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	181510000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	300140000	USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	637000	USD
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	39900000	USD
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	29000000	USD
CY2022Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2021Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	42779000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	90065000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	101888000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	79598000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	164902000	USD
CY2022Q1	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	10342000	USD
CY2021Q2	lndc	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	9581000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	961000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6140000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	544000	USD
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2870000	USD
CY2022Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29482000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29482000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29333000	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29333000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	29000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	166943000	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	165533000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22188000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	38580000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-712000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1358000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	144072000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	202784000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	325582000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	502924000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	53074000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44690000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	138158000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126629000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	39179000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	30249000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	99113000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	90739000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	13895000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	14441000	USD
	us-gaap	Gross Profit GrossProfit	39045000	USD
	us-gaap	Gross Profit GrossProfit	35890000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2056000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1843000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5785000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5523000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9725000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8134000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27207000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27968000	USD
CY2022Q1	us-gaap	Legal Fees LegalFees	0	USD
CY2021Q1	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	0	USD
	us-gaap	Legal Fees LegalFees	1763000	USD
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	5865000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	2023000	USD
	us-gaap	Restructuring Charges RestructuringCharges	8406000	USD
	us-gaap	Restructuring Charges RestructuringCharges	2826000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	17646000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	12000000	USD
	us-gaap	Operating Expenses OperatingExpenses	41398000	USD
	us-gaap	Operating Expenses OperatingExpenses	38080000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3751000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2441000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2353000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2190000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	20000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	66000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	4105000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2939000	USD
	us-gaap	Interest Expense InterestExpense	13877000	USD
	us-gaap	Interest Expense InterestExpense	6609000	USD
CY2022Q1	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2021Q1	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-1110000	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-1110000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	454000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	72000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	642000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	64000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7382000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1523000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15522000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-9814000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-276000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-58000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5012000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1025000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-7106000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1465000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10510000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-8789000	USD
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5744000	USD
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4033000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-50258000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-21010000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12850000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5498000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60768000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29799000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.19
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.19
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.14
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.14
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.71
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.71
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.72
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.72
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2022Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.24
CY2021Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.05
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.36
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.14
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.30
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.19
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.71
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.72
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29482000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29323000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29459000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29282000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29482000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29323000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29459000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29282000	shares
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-101000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-99000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-291000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax	-327000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	104000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	387000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	646000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1092000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	104000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	387000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	646000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1092000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12746000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5111000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-60122000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	428000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28707000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	202784000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	620000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-9477000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	366000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	193865000	USD
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	84000	USD
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	686000	USD
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-38441000	USD
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	176000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	156202000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	6000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	622000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12850000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	104000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	144072000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	231044000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	82000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	892000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-11000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	304000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	221158000	USD
CY2020Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2020Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	215000	USD
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	895000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-13301000	USD
CY2020Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	401000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	208938000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	797000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5498000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	387000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	204624000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60768000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29799000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	32057000	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14488000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14808000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	5185000	USD
	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	7881000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5471000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7307000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-4354000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1928000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2584000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-25000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-39000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-14000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	284000	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	0	USD
	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-11800000	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-1110000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	551000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	12000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	7525000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-6345000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11910000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10468000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1448000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-350000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13055000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6372000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3849000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2184000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-4195000	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3186000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	204000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1243000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24435000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10600000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	73500000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	45100000	USD
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18539000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11383000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1096000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12885000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	101157000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1502000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	150000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	86376000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	114095000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	45011000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	83000000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	34111000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	119400000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	518000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	297000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	169000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	9615000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-76163000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10407000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	559000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1695000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1295000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	553000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1854000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2248000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1765000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1124000	USD
CY2022Q1	lndc	Number Of Product Category NumberOfProductCategory	2	product
CY2022Q1	lndc	Number Of Revenue Category NumberOfRevenueCategory	3	revenue
	us-gaap	Repayments Of Debt RepaymentsOfDebt	67900000	USD
	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year is the 52- or 53-week period that ends on the last Sunday of May with quarters within each year ending on the last Sunday of August, November, and February; however, in instances where the last Sunday would result in a quarter being 12-weeks in length, the Company’s policy is to extend that quarter to the following Sunday. A 14th week is included in the fiscal year every five or six years to realign the Company’s fiscal quarters with calendar quarters.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the nine months ended February 27, 2022 are not necessarily indicative of the results that may be expected for an entire fiscal year because there is some seasonality in Curation Foods’ business and the order patterns of Lifecore’s customers which may lead to significant fluctuations in Landec’s quarterly results of operations.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and judgments that affect the amounts reported in the financial statements and accompanying notes. The accounting estimates that require management’s most significant and subjective judgments include revenue recognition; loss contingencies; sales returns and credit losses; recognition and measurement of current and deferred income tax assets and liabilities; the assessment of recoverability of long-lived and indefinite lived assets (including intangible assets), and inventory; and the valuation and recognition of stock-based compensation.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates involve the consideration of complex factors and require management to make judgments. The analysis of historical and future trends can require extended periods of time to resolve and are subject to change from period to period. The actual results may differ from management’s estimates.</span></div>
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1854000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1159000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2248000	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	360000	USD
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2021Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	136000	USD
CY2021Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2020Q2	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2020Q2	us-gaap	Restricted Cash RestrictedCash	193000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1854000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1295000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2248000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	553000	USD
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	42387000	USD
CY2021Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40204000	USD
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	26644000	USD
CY2021Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	16644000	USD
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	4669000	USD
CY2021Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	6228000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	73700000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	63076000	USD
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	85000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-14000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	USD
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	186000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	284000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	385000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	85000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1400000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	4100000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	1400000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5100000	USD
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-300000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	USD
CY2020Q3	lndc	Loss Contingency Number Of Former Owner Plaintiff LossContingencyNumberOfFormerOwnerPlaintiff	1	plaintiff
CY2021Q1	us-gaap	Insurance Recoveries InsuranceRecoveries	1600000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	778000	shares
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3800000	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	622000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	797000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1928000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2584000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3300000	USD
CY2010Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	3800000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-12850000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5498000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-60768000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29799000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29482000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29323000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29459000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	29282000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29482000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29323000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29459000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29282000	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.32
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.10
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	900000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	800000	USD
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	900000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	83712000	USD
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	170000000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	83712000	USD
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	170000000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4114000	USD
CY2021Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5098000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	79598000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	164902000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	79598000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	164902000	USD
CY2020Q4	lndc	Number Of Credit Agreements NumberOfCreditAgreements	2	creditAgreement
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q1	lndc	Number Of Natural Food Brands NumberOfNaturalFoodBrands	3	brand
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	53074000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	13895000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7106000	USD
CY2022Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5744000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	2834000	USD
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	20000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	4105000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-276000	USD
CY2022Q1	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	138158000	USD
	us-gaap	Gross Profit GrossProfit	39045000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-10510000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-50258000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	8059000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	66000	USD
	us-gaap	Interest Expense InterestExpense	13877000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5012000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44690000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	14441000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1465000	USD
CY2021Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-4033000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	2237000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	13000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2939000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-58000	USD
CY2021Q1	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	126629000	USD
	us-gaap	Gross Profit GrossProfit	35890000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8789000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-21010000	USD
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	6582000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000	USD
	us-gaap	Interest Expense InterestExpense	6609000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1025000	USD
	lndc	Corporate Overhead Expense Benefit CorporateOverheadExpenseBenefit	0	USD
CY2022Q1	us-gaap	Restructuring Costs RestructuringCosts	5865000	USD
	us-gaap	Restructuring Costs RestructuringCosts	8406000	USD
	us-gaap	Restructuring Costs RestructuringCosts	16223000	USD
CY2022Q1	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	20000000	USD

Files In Submission

Name	View Source	Status
0001005286-22-000020-index-headers.html	Edgar Link	pending
0001005286-22-000020-index.html	Edgar Link	pending
0001005286-22-000020.txt	Edgar Link	pending
0001005286-22-000020-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lndc-20220227.htm	Edgar Link	pending
lndc-20220227.xsd	Edgar Link	pending
lndc-20220227xexx311.htm	Edgar Link	pending
lndc-20220227xexx312.htm	Edgar Link	pending
lndc-20220227xexx321.htm	Edgar Link	pending
lndc-20220227xexx322.htm	Edgar Link	pending
lndc-20220227_cal.xml	Edgar Link	unprocessable
lndc-20220227_def.xml	Edgar Link	unprocessable
lndc-20220227_htm.xml	Edgar Link	completed
lndc-20220227_lab.xml	Edgar Link	unprocessable
lndc-20220227_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2022 Q2 Form 10-Q Financial Statement

#000100528622000020 Filed on April 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr

2022 Q2 Form 10-Q Financial Statement

#000100528622000020 Filed on April 07, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFCR
LIFECORE BIOMEDICAL, INC. \DE\ Stock $lfcr